Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Envoy Medical, Inc.

NASDAQ: COCH · Industrial Applications and Services · 5 alerts · CIK 1840877

Share price
$6.92Close, Nov 16
Market cap
$53.6M
Shares outstanding
7.74MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Envoy Medical, Inc. filings on SEC EDGAR ↗

7:31 AM ET 10-Q
Financial Results

Envoy Medical Q3 2026 Results: Net Loss of $3.93M, Loss Narrows

For the nine months ended September 30, 2026, Envoy Medical reported a net loss of $14.3 million, an improvement from the $17.2 million loss in the prior year period. The company strengthened its balance sheet through a February 2026 offering, increasing cash to $14.6 million and significantly reducing its stockholders' deficit.

Key figure
Net loss $3.93M
7:14 AM ET 8-K
Financial Results

Envoy Medical Financial Results

Envoy Medical reported third quarter 2026 financial results and provided a clinical update on its Acclaim fully implanted cochlear implant. The company reached a six-month follow-up milestone for its full pivotal trial cohort and submitted the second module of its Modular PMA application to the FDA.

“We continued to make significant progress with our investigational fully implanted cochlear implant during the third quarter, as we approach an extremely exciting 2027. Not only did we report encouraging 12-month data from the first 10 participants in our trial, but we also surpassed the three-month follow-up mark for the full cohort. Since quarter end, we have now surpassed the six-month follow-up milestone. We remain on track for all participants to complete their 12-month visits by early in the second quarter of 2027. Each milestone brings us closer to offering cochlear implant candidates a fully implanted option they have wanted for decades.”

Brent Lucas, Chief Executive Officer of Envoy Medical

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.